https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and
34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Sentinel Initiative Events
08/21/2018
Sentinel Initiative Events
08/21/2018
https://www.sentinelinitiative.org/methods-data-tools/methods/near-real-time-monitoring-critical-drugs-care-patients-covid-19
Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19
Methods, Data, & Tools
04/20/2020
Methods, Data, & Tools
04/20/2020
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and
36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Publications and Presentations
09/16/2020
Publications and Presentations
09/16/2020
https://www.sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and
A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System
Publications and Presentations
04/18/2021
Publications and Presentations
04/18/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related
Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology
Publications and Presentations
08/25/2021
Publications and Presentations
08/25/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
09/24/2021
Methods, Data, & Tools
09/24/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses
02/18/2022
Analyses
02/18/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses
03/01/2022
Analyses
03/01/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
03/16/2022
Methods, Data, & Tools
03/16/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations
08/26/2022
Publications and Presentations
08/26/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings
Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and
Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study
Publications and Presentations
04/17/2023
Publications and Presentations
04/17/2023
https://www.sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods
Subset Calibration Methods
Methods, Data, & Tools
05/08/2023
Methods, Data, & Tools
05/08/2023
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz
Zarxio (Filgrastim-sndz) & Signal Identification
Studies
06/01/2023
Studies
06/01/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19
Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021
Publications and Presentations
07/11/2023
Publications and Presentations
07/11/2023
https://www.sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Methods, Data, & Tools
07/31/2023
Methods, Data, & Tools
07/31/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
Publications and Presentations
08/25/2023
Publications and Presentations
08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles
Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic
Publications and Presentations
08/27/2023
Publications and Presentations
08/27/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-0
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis
Analyses
03/08/2024
Analyses
03/08/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures
Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints
Publications and Presentations
04/02/2024
Publications and Presentations
04/02/2024
https://www.sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
07/17/2024
Studies
07/17/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-strategies
High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large
Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis
Analyses
09/17/2024
Analyses
09/17/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
09/18/2024
Publications and Presentations
09/18/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/applications-real-world-data-rwd-fda-s-sentinel-system
Applications of Real-World Data (RWD) in FDA’s Sentinel System
Publications and Presentations
10/24/2024
Publications and Presentations
10/24/2024
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal-0
Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis
Analyses
11/01/2024
Analyses
11/01/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-partially-observed
High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
01/22/2025
Publications and Presentations
01/22/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/interplay-adverse-events-spontaneous-reporting-and
Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management
Publications and Presentations
01/27/2025
Publications and Presentations
01/27/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/practical-overview-real-life-challenges-leveraging-ehr-data
A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System
Publications and Presentations
02/14/2025
Publications and Presentations
02/14/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal
A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference
Publications and Presentations
03/25/2025
Publications and Presentations
03/25/2025
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system
Sentinel Routine Querying System
Methods, Data, & Tools
04/01/2025
Methods, Data, & Tools
04/01/2025
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
04/01/2025
Methods, Data, & Tools
04/01/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-inhaler-triple-therapy-patients-chronic
Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
05/01/2025
Analyses
05/01/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns
Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis
Analyses
05/06/2025
Analyses
05/06/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first
Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis
Analyses
05/06/2025
Analyses
05/06/2025
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/livdelzi-seladelpar
Assessment of ARIA Sufficiency: Livdelzi (seladelpar)
Sufficiency Assessments
05/09/2025
Sufficiency Assessments
05/09/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-1
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
05/13/2025
Analyses
05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
05/13/2025
Analyses
05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-0
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
05/13/2025
Analyses
05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-2
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United States Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
05/13/2025
Analyses
05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-1
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis
Analyses
05/13/2025
Analyses
05/13/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-treatment-effects-observational-data-missing
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods
Publications and Presentations
05/15/2025
Publications and Presentations
05/15/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-single-and-multiple-inhaler-triple
Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
05/15/2025
Analyses
05/15/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-confounding-covariates-trinetx-descriptive
Characterization of Confounding Covariates in the TriNetX: A Descriptive Analysis
Analyses
05/16/2025
Analyses
05/16/2025
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2025-ispe-annual-meeting
2025 ISPE Annual Meeting
Sentinel Initiative Events
08/22/2025
Sentinel Initiative Events
08/22/2025